業績
原著（英文）
| 2024 | Araki M, Mitsuhashi T, Yatabe Y, Arai T, Yokota H, Okita H, Sakurai M, Tsukada N, Kataoka K, Matsushita H. Simple flow cytometry method using a myeloma panel that easily reveals clonal proliferation of mature B-cells. Clin Chem Lab Med. 2024 Aug 5. doi: 10.1515/cclm-2024-0359. |
| 2024 | Wakui M, Fujimori Y, Ozaki Y, Oka S, Ziparo M, Osada E, Kondo Y, Nakagawa T, Nakamura S, Matsushita H. Comparison of clot waveform analysis with or without adjustment between prothrombin time and activated partial thromboplastin time assays to assess in vitro effects of direct oral anticoagulants. Clin Chim Acta. 2024 Aug 15;562:119887. doi: 10.1016/j.cca.2024.119887. |
| 2024 | Aruga Y, Ikeda C, Matsushita H, Makita S, Fukuhara S, Munakata W, Izutsu K, Matsui H. The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype. Sci Rep. 2024 Jun 11;14(1):13452. doi: 10.1038/s41598-024-64398-6. |
| 2024 | Uwamino Y, Aoki W, Inose R, Kamoshita Y, Mikita K, Namkoong H, Nishimura T, Matsushita H, Hasegawa N. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan. Microbiol Spectr. 2024 Jun 4;12(6):e0021824. doi: 10.1128/spectrum.00218-24. |
| 2024 | Mori H, Mitsuhashi T, Yatabe Y, Kato J, Tsujikawa H, Matsushita H. Blastic transformation of follicular lymphoma. EJHaem. 2024 Jan 5;5(1):269-270. doi: 10.1002/jha2.823. eCollection 2024 Feb. |
| 2024 | Inoue H, Kanda T, Hayashi G, Munenaga R, Yoshida M, Hasegawa K, Miyagawa T, Kurumada Y, Hasegawa J, Wada T, Horiuchi M, Yoshimatsu Y, Itoh F, Maemoto Y, Arasaki K, Wakana Y, Watabe T, Matsushita H, Harada H, Tagaya M. A MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis. J Cell Biol. 2024 Mar 4;223(3):e202303102. doi: 10.1083/jcb.202303102. |
| 2024 | Uwamino Y, Tanaka S, Shibata A, Kurafuji T, Ishihara H, Sato Y, Matsushita H. The utility of smartphone-based quantitative analysis of SARS-CoV-2-specific antibody lateral flow assays. Diagn Microbiol Infect Dis. 2024 Mar;108(3):116166. doi: 10.1016/j.diagmicrobio.2023.116166. |
| 2024 | Morita A, Namkoong H, Uwamino Y, Mitarai S, Aono A, Asakura T, Yagi K, Tanaka H, Azekawa S, Nakagawara K, Kaji M, Nagao G, Kamata H, Matsushita H, Fukunaga K, Hasegawa N. Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences. J Infect Chemother. 2024 Feb;30(2):159-163. doi: 10.1016/j.jiac.2023.09.016. |
| 2024 | Kobashi Y, Kawamura T, Shimazu Y, Kaneko Y, Nishikawa Y, Sugiyama A, Tani Y, Nakayama A, Yoshida M, Zho T, Yamamoto C, Saito H, Takita M, Wakui M, Kodama T, Tsubokura M. Kinetics of humoral and cellular immune responses 5 months post-COVID-19 booster dose by immune response groups at the peak immunity phase: An observational historical cohort study using the Fukushima vaccination community survey. Vaccine X. 2024 Sep 12;20:100553. doi: 10.1016/j.jvacx.2024.100553. eCollection 2024 Oct. |
| 2024 | Watanabe S, Sawano T, Saito H, Ozaki A, Wakui M, Zhao T, Yamamoto C, Kobashi Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Shimmura H, Tsubokura M. SARS-CoV-2 spike protein antibody titers after the fourth dose of BNT162b2 vaccine among Japanese patients undergoing hemodialysis: a single-center study. Front Immunol. 2024 Aug 21;15:1412918. doi: 10.3389/fimmu.2024.1412918. eCollection 2024. |
| 2024 | Yamamoto C, Kobashi Y, Kawamura T, Nishikawa Y, Saito H, Oguro F, Zhao T, Takita M, Sawano T, Ozaki A, Abe T, Ito N, Kaneko Y, Nakayama A, Wakui M, Kodama T, Tsubokura M. Group of longitudinal adverse event patterns after the fourth dose of COVID-19 vaccination with a latent class analysis. Front Public Health. 2024 Jul 30;12:1406315. doi: 10.3389/fpubh.2024.1406315. eCollection 2024. |
| 2024 | Nakamura N, Kobashi Y, Kim KS, Park H, Tani Y, Shimazu Y, Zhao T, Nishikawa Y, Omata F, Kawashima M, Yoshida M, Abe T, Saito Y, Senoo Y, Nonaka S, Takita M, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Jeong YD, Tatematsu D, Akao M, Sato Y, Iwanami S, Fujita Y, Wakui M, Aihara K, Kodama T, Shibuya K, Iwami S, Tsubokura M. Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population. PLOS Digit Health. 2024 May 3;3(5):e0000497. doi: 10.1371/journal.pdig.0000497. eCollection 2024 May. |
| 2024 | Zhao T, Tani Y, Makino-Okamura C, Takita M, Yamamoto C, Kawahara E, Abe T, Sugiura S, Yoshimura H, Uchiyama T, Yamazaki I, Ishigame H, Ueno T, Okuma K, Wakui M, Fukuyama H, Tsubokura M. Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan. Front Immunol. 2024 Mar 18;15:1337520. doi: 10.3389/fimmu.2024.1337520. eCollection 2024. |
| 2024 | Yamamoto T, Hayashida T, Masugi Y, Oshikawa K, Hayakawa N, Itoh M, Nishime C, Suzuki M, Nagayama A, Kawai Y, Hishiki T, Matsuura T, Naito Y, Kubo A, Yamamoto A, Yoshioka Y, Kurahori T, Nagasaka M, Takizawa M, Takano N, Kawakami K, Sakamoto M, Wakui M, Yamamoto T, Kitagawa Y, Kabe Y, Horisawa K, Suzuki A, Matsumoto M, Suematsu M. PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer. Cancer Res. 2024 Apr 1;84(7):1065-1083. doi: 10.1158/0008-5472.CAN-23-2266. |
| 2024 | Kaku Y, Uriu K, Kosugi Y, Okumura K, Yamasoba D, Uwamino Y, Kuramochi J, Sadamasu K, Yoshimura K, Asakura H, Nagashima M; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infect Dis. 2024 Jul;24(7):e416. doi: 10.1016/S1473-3099(24)00298-6. |
| 2024 | Uchida S, Uno S, Kondo M, Uwamino Y, Namkoong H, Nishimura T, Misawa K, Kashimura S, Yamato K, Ishizaka T, Nagashima K, Kitagawa Y, Hasegawa N. Factors affecting motivation for receiving a booster dose of the COVID-19 vaccine among Japanese university students and staff: a cross-sectional questionnaire survey. Sci Rep. 2024 Apr 5;14(1):8009. doi: 10.1038/s41598-024-58603-9. |
| 2024 | Oba J, Toriya M, Uwamino Y, Matsuo K. Using a Systems Engineering Approach to Build a PCR Testing System at a Medical School During the COVID-19 Pandemic. Risk Manag Healthc Policy. 2024 Mar 21;17:649-662. doi: 10.2147/RMHP.S441618. eCollection 2024. |
| 2024 | Yoshifuji A, Toda M, Oyama E, Nakayama T, Mise-Omata S, Kikuchi K, Yoshizawa M, Kato N, Wakai H, Koibuchi K, Morimoto K, Uwamino Y, Namkoong H, Shibata A, Wakabayashi K, Fujino M, Komatsu M, Mochizuki N, Kondo N, Yoshimura A, Hasegawa N, Ryuzaki M. Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients. Clin Exp Nephrol. 2024 Jul;28(7):674-682. doi: 10.1007/s10157-024-02477-8. |
| 2024 | Matsubara Y, Kiyohara H, Mikami Y, Nanki K, Namkoong H, Chubachi S, Tanaka H, Azekawa S, Sugimoto S, Yoshimatsu Y, Sujino T, Takabayashi K, Hosoe N, Sato T, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Fukunaga K, Kanai T; Japan COVID-19 Task Force. J Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study. Gastroenterol. 2024 Mar;59(3):195-208. doi: 10.1007/s00535-023-02071-x. |
| 2024 | Yamayoshi S, Nagai E, Mitamura K, Hagihara M, Kobayashi R, Takahashi S, Shibata A, Uwamino Y, Hasegawa N, Iqbal A, Kamimaki I, Iwatsuki-Horimoto K, Nagamura-Inoue T, Kawaoka Y. Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies between December 2021 and march 2023 in Japan. Epidemiol Infect. 2024 Jan 23;152:e24. doi: 10.1017/S0950268824000141. |
| 2024 | Kosugi Y, Kaku Y, Hinay AA Jr, Guo Z, Uriu K, Kihara M, Saito F, Uwamino Y, Kuramochi J, Shirakawa K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Sato K. Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals. Lancet Infect Dis. 2024 Mar;24(3):e147-e148. doi: 10.1016/S1473-3099(23)00784-3. |
| 2024 | Uno S, Goto R, Honda K, Uchida S, Uwamino Y, Namkoong H, Yoshifuji A, Mikita K, Takano Y, Matsumoto M, Kitagawa Y, Hasegawa N. Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 Polymerase Chain Reaction Screening: A Cost-Utility Analysis. Clin Infect Dis. 2024 Jan 25;78(1):57-64. doi: 10.1093/cid/ciad463. |
| 2024 | Saito T, Tsuruta H, Iwata J, Kajino A, Sakata S, Ryuzaki T, Saji M, Asami M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Kubo S, Amaki M, Kodama K, Yamaguchi J, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Nakashima M, Otsuka T, Yamamoto M, Ieda M, Hayashida K.Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry. Int J Cardiol. 2024 Sep 24;418:132595. doi: 10.1016/j.ijcard.2024.132595. |
| 2024 | Shimohama S, Katsumata M, Azami S, Kitagawa S, Tsuruta H, Inohara T, Nakahara J, Izawa Y. Warfarin Therapy and Percutaneous Left Atrial Appendage Closure for a Patient with Atrial Fibrillation and Antithrombin-III Deficiency. Keio J Med. 2024 Sep 25;73(3):27-30. doi: 10.2302/kjm.2023-0017-CR. |
| 2024 | Saito T, Inohara T, Tsuruta H, Yashima F, Shimizu H, Fukuda K, Ohno Y, Nishina H, Izumo M, Asami M, Naganuma T, Mizutani K, Yamawaki M, Tada N, Yamanaka F, Shirai S, Noguchi M, Ueno H, Takagi K, Watanabe Y, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators. Pre-Existing Left Bundle Branch Block and Clinical Outcomes After Transcatheter Aortic Valve Replacement. JACC Asia. 2024 Jan 9;4(4):306-319. doi: 10.1016/j.jacasi.2023.11.007. eCollection 2024 Apr. |
| 2024 | Sakata S, Hayashida K, Iwata J, Kajino A, Imaeda S, Ryuzaki T, Tsuruta H, Shimizu H, Ieda M. Novel "Balloon Anchoring" Technique to Control a Migrated Transcatheter Heart Valve. JACC Cardiovasc Interv. 2024 Feb 12;17(3):437-438. doi: 10.1016/j.jcin.2023.11.028. |
| 2024 | Iwata J, Kobari Y, Tsuruta H, Shimizu H, Hayashida K, Ieda M. Rescue transcatheter aortic valve replacement to an extremely small transcatheter valve. Cardiovasc Interv Ther. 2024 Jan;39(1):99-100. doi: 10.1007/s12928-023-00958-3. |
| 2024 | de Jongh MC, Tsuruta H, Hayashida K, Hase H, Yoshijima N, Saito T, Myojin S, Kobari Y, Ryuzaki T, Imaeda S, Shirakawa K, Okada M, Endo J, Shinada K, Itabashi Y, Inohara T, Kohsaka S, Kato J, Takahashi T, Yamazaki M, Shimizu H, Fukuda K. Right Ventricular Dysfunction in Patients With Concomitant Tricuspid Regurgitation Undergoing Transcatheter Aortic Valve Implantation. Circ J. 2024 Mar 25;88(4):451-459. doi: 10.1253/circj.CJ-22-0262. |
| 2024 | Takizawa T, Ihara K, Unekawa M, Iba C, Kagawa S, Watanabe N, Nakayama S, Sakurai K, Miyazaki N, Ishida N, Takemura R, Shibata M, Izawa Y, Chubachi S, Fukunaga K, Nakahara J. Effects of passive smoking on cortical spreading depolarization in male and female mice.J Headache Pain. 2024 Oct 2;25(1):162. doi: 10.1186/s10194-024-01867-3. |
| 2024 | Ihara K, Takahashi N, Ohtani S, Watanabe N, Ishizuchi K, Takemura R, Tokuyasu D, Sekiguchi K, Miyazaki N, Imai S, Hori S, Nakahara J, Takizawa T. Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in Japan. Intern Med. 2024 Aug 8. doi: 10.2169/internalmedicine.4037-24. |
| 2024 | Ishii R, Ishizuchi K, Watanabe N, Fukazawa R, Trivedi M, Nakahara J, Takizawa T. Efficacy and tolerability of 100 mg of lasmiditan for migraine: A multi-center, prospective observational real-world study in Japan. Cephalalgia. 2024 Jun;44(6):3331024241258695. doi: 10.1177/03331024241258695. |
| 2024 | Takizawa T, Ihara K, Watanabe N, Takemura R, Takahashi N, Miyazaki N, Shibata M, Suzuki K, Imai N, Suzuki N, Hirata K, Takeshima T, Nakahara J. CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society. J Headache Pain. 2024 Mar 15;25(1):39. doi: 10.1186/s10194-024-01737-y. |
| 2024 | Ihara K, Takizawa T, Watanabe N, Nakahara J, Potential benefits and possible risks of CGRP-targeted multitherapy in migraine. Martelletti P.Expert Opin Drug Metab Toxicol. 2024 Jan-Feb;20(1-2):1-4. doi: 10.1080/17425255.2024.2316131. |
| 2024 | Sekiguchi K, Huh S, Watanabe N, Miyazaki N, Ishizuchi K, Iba C, Tagashira Y, Shibata M, Takemura R, Nakahara J, Takizawa T. Prevalence of Primary Headache in Nurses in Japan: A Cross-sectional Single-center Study. Intern Med. 2024 May 1;63(9):1217-1222. doi: 10.2169/internalmedicine.1757-23. |
| 2023 | Ozaki Y, Wakui M, Oka S, Fujimori Y, Kondo Y, Nakamura S, Osada E, Nakagawa T, Katagiri H, Matsushita H. Effects of DOAC-Stop on clot waveform analysis of plasma spiked with antithrombin-dependent and antithrombin-independent anticoagulants. Int J Lab Hematol. 2023 Dec;45(6):979-983. doi: 10.1111/ijlh.14120. |
| 2023 | Awane M, Wakui M, Ozaki Y, Kondo Y, Oka S, Fujimori Y, Yatabe Y, Arai T, Yamada Y, Hori S, Obara H, Hasegawa Y, Matsushita H. Clot waveform analysis for perioperative hemostatic monitoring in a hemophilia A patient on emicizumab undergoing liver transplantation. Clin Chim Acta. 2023 Apr 1;544:117339. doi: 10.1016/j.cca.2023.117339. |
| 2023 | Tsubokura M, Kojima M, Nakabayashi S, Takahashi N, Takeuchi S, Aruga Y, Ikeda C, Maezawa N, Okazaki K, Uchida S, Watanabe M, Aoki J, Ito A, Tanaka T, Inamoto Y, Kim SW, Matsushita H, Fukuda T. EDTA-induced pseudothrombocytopenia in hematopoietic stem cell donor. Clin Case Rep. 2023 Apr 5;11(4):e7023. doi: 10.1002/ccr3.7023. eCollection 2023 Apr. |
| 2023 | Uwamino Y, Nagashima K, Yoshifuji A, Suga S, Nagao M, Fujisawa T, Ryuzaki M, Takemoto Y, Namkoong H, Wakui M, Matsushita H, Hasegawa N, Sato Y, Murata M. Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination. NPJ Vaccines. 2023 Mar 6;8(1):33. doi: 10.1038/s41541-023-00626-w. |
| 2023 | Uwamino Y, Yokoyama T, Sato Y, Shibata A, Kurafuji T, Tanabe A, Noguchi M, Arai T, Ohno A, Yokota H, Namkoong H, Nishimura T, Kosaki K, Hasegawa N, Wakui M, Murata M, Matsushita H. Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine. Vaccine. 2023 Feb 24;41(9):1545-1549. doi: 10.1016/j.vaccine.2023.01.049. |
| 2023 | Tani Y, Takita M, Wakui M, Saito H, Nishiuchi T, Zhao T, Yamamoto C, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Shinaha R, Tsubokura M. Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan. Front Immunol. 2023 Aug 16;14:1240425. doi: 10.3389/fimmu.2023.1240425. eCollection 2023. |
| 2023 | Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Saito H, Yamamoto C, Zhao T, Takita M, Ito N, Tatsuno K, Kaneko Y, Nakayama A, Kodama T, Wakui M, Takahashi K, Tsubokura M. Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination. Sci Rep. 2023 Jun 7;13(1):9264. doi: 10.1038/s41598-023-36429-1. |
| 2023 | Tani Y, Takita M, Kobashi Y, Wakui M, Zhao T, Yamamoto C, Saito H, Kawashima M, Sugiura S, Nishikawa Y, Omata F, Shimazu Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Kami M, Tsubokura M. Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan. Vaccines (Basel). 2023 Apr 29;11(5):920. doi: 10.3390/vaccines11050920. |
| 2023 | Kawashima M, Saito H, Nishiuchi T, Yoshimura H, Wakui M, Tani Y, Nishikawa Y, Omata F, Takita M, Zhao T, Yamamoto C, Kobashi Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Sawano T, Shibuya K, Kazama J, Shineha R, Tsubokura M. Antibody and T-Cell Responses against SARS-CoV-2 after Booster Vaccination in Patients on Dialysis: A Prospective Observational Study. Vaccines (Basel). 2023 Jan 25;11(2):260. doi: 10.3390/vaccines11020260. |
| 2023 | Maeda R, Seki N, Uwamino Y, Wakui M, Nakagama Y, Kido Y, Sasai M, Taira S, Toriu N, Yamamoto M, Matsuura Y, Uchiyama J, Yamaguchi G, Hirakawa M, Kim YG, Mishima M, Yanagita M, Suematsu M, Sugiura Y. Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19. Nat Commun. 2023 Dec 20;14(1):8469. doi: 10.1038/s41467-023-44266-z. |
| 2023 | Saito H, Yoshimura H, Yoshida M, Tani Y, Kawashima M, Uchiyama T, Zhao T, Yamamoto C, Kobashi Y, Sawano T, Imoto S, Park H, Nakamura N, Iwami S, Kaneko Y, Nakayama A, Kodama T, Wakui M, Kawamura T, Tsubokura M. Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays. Vaccines (Basel). 2023 Nov 7;11(11):1694. doi: 10.3390/vaccines11111694. |
| 2023 | Kubo A, Masugi Y, Hase T, Nagashima K, Kawai Y, Takizawa M, Hishiki T, Shiota M, Wakui M, Kitagawa Y, Kabe Y, Sakamoto M, Yachie A, Hayashida T, Suematsu M. Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging. Antioxidants (Basel). 2023 Jan 20;12(2):240. doi: 10.3390/antiox12020240. |
| 2023 | Itagaki M, Iketani O, Enoki Y, Chuang VTG, Taguchi K, Uno S, Uchida S, Namkoong H, Uwamino Y, Takano Y, Hasegawa N, Matsumoto K. Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications. Biol Pharm Bull. 2023;46(12):1832-1837. doi: 10.1248/bpb.b23-00521. |
| 2023 | Tanaka H, Namkoong H, Chubachi S, Irie S, Uwamino Y, Lee H, Azekawa S, Otake S, Nakagawara K, Fukushima T, Watase M, Kusumoto T, Masaki K, Kamata H, Ishii M, Okada Y, Takano T, Imoto S, Koike R, Kimura A, Miyano S, Ogawa S, Kanai T, Sato TA, Fukunaga K; Japan COVID-19 Task Force. Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells. Int J Infect Dis. 2023 Oct;135:41-44. doi: 10.1016/j.ijid.2023.07.030. |
| 2023 | Toda M, Yoshifuji A, Nakayama T, Mise-Omata S, Oyama E, Uwamino Y, Namkoong H, Komatsu M, Yoshimura A, Hasegawa N, Kikuchi K, Ryuzaki M. Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis. Vaccines (Basel). 2023 Jul 6;11(7):1214. doi: 10.3390/vaccines11071214. |
| 2023 | Uno S, Goto R, Honda K, Tokuda M, Kamata H, Chubachi S, Yamamoto R, Sato Y, Homma K, Uchida S, Namkoong H, Uwamino Y, Sasaki J, Fukunaga K, Hasegawa N. Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study. Cost Eff Resour Alloc. 2023 Jul 16;21(1):43. doi: 10.1186/s12962-023-00453-9. |
| 2023 | Yamamoto S, Yamayoshi S, Ito M, Sakai-Tagawa Y, Nakachi I, Baba R, Kamimoto S, Ogura T, Hagiwara S, Kato H, Nakajima H, Uwamino Y, Yagi K, Sugaya N, Nagai H, Saito M, Adachi E, Koga M, Tsutsumi T, Duong C, Okuda M, Murakami J, Furusawa Y, Ujie M, Iwatsuki-Horimoto K, Yotsuyanagi H, Kawaoka Y. Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination. iScience. 2023 Jun 25;26(7):107208. doi: 10.1016/j.isci.2023.107208. eCollection 2023 Jul 21. |
| 2023 | Kaji M, Namkoong H, Nagao G, Azekawa S, Nakagawara K, Tanaka H, Morita A, Asakura T, Kamata H, Uwamino Y, Yoshida M, Fukunaga K, Hasegawa N. Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review. Infect Drug Resist. 2023 Jun 20;16:3955-3963. doi: 10.2147/IDR.S415197. eCollection 2023. |
| 2023 | Tokimatsu I, Matsumoto T, Tsukada H, Fujikura Y, Miki M, Morinaga Y, Sato J, Wakamura T, Kiyota H, Tateda K, Yanagisawa H, Sasaki T, Ikeda H, Horikawa H, Takahashi H, Seki M, Mori Y, Takeda H, Kurai D, Hasegawa N, Uwamino Y, Kudo M, Yamamoto M, Nagano Y, Nomura S, Tetsuka T, Hosokai M, Aoki N, Yamamoto Y, Iinuma Y, Mikamo H, Suematsu H, Maruyama T, Kawabata A, Sugaki Y, Nakamura A, Fujikawa Y, Fukumori T, Ukimura A, Kakeya H, Niki M, Yoshida K, Kobashi Y, Tokuyasu H, Yatera K, Ikegami H, Fujita M, Matsumoto T, Yanagihara K, Matsuda J, Hiramatsu K, Shinzato T. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2023 Aug;29(8):731-743. doi: 10.1016/j.jiac.2023.04.008. |
| 2023 | Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, Morita T, Kato Y, Liu YC, Motooka D, Naito Y, Takuwa A, Sugihara F, Tanaka K, Wing JB, Sonehara K, Tomofuji Y; Japan COVID-19 Task Force; Namkoong H, Tanaka H, Lee H, Fukunaga K, Hirata H, Takeda Y, Okuzaki D, Kumanogoh A, Okada Y. Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity. Nat Genet. 2023 May;55(5):753-767. doi: 10.1038/s41588-023-01375-1. |
| 2023 | Uwamino Y, Aono A, Tomita Y, Morimoto K, Kawashima M, Kamata H, Sasaki Y, Nagai H, Hasegawa N, Mitarai S. Diagnostic Utility of a Mycobacterium Multiplex PCR Detection Panel for Tuberculosis and Nontuberculous Mycobacterial Infections. Microbiol Spectr. 2023 Jun 15;11(3):e0516222. doi: 10.1128/spectrum.05162-22. |
| 2023 | Bramer LM, Hontz RD, Eisfeld AJ, Sims AC, Kim YM, Stratton KG, Nicora CD, Gritsenko MA, Schepmoes AA, Akasaka O, Koga M, Tsutsumi T, Nakamura M, Nakachi I, Baba R, Tateno H, Suzuki S, Nakajima H, Kato H, Ishida K, Ishii M, Uwamino Y, Mitamura K, Paurus VL, Nakayasu ES, Attah IK, Letizia AG, Waters KM, Metz TO, Corson K, Kawaoka Y, Gerbasi VR, Yotsuyanagi H, Iwatsuki-Horimoto K. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections. Heliyon. 2023 Mar;9(3):e13795. doi: 10.1016/j.heliyon.2023.e13795. |
| 2023 | Kobari Y, Inohara T, Tsuruta H, Yashima F, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Yamawaki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Watanabe Y, Yamamoto M, Hayashida K. No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry. JACC Cardiovasc Interv. 2023 Jan 9;16(1):79-91. doi: 10.1016/j.jcin.2022.10.010. |
| 2023 | Hashiguchi MH, Chubachi S, Yamasawa W, Otsuka K, Harada N, Miyao N, Nakamura H, Asano K, Yamaguchi K, Fukunaga K. Interaction of BMI and respiratory status in obstructive sleep apnea, a cross-sectional COPD study. NPJ Prim Care Respir Med. 2023 Aug 15;33(1):30. doi: 10.1038/s41533-023-00351-w. |
| 2023 | Sogano J, Kosugi K, Okano A, Nihei Y, Watanabe N, Nakahara J, Toda M. Probable Sporadic Creutzfeldt-Jakob Disease Presenting as Refractory Status Epilepticus in a Poststroke Epilepsy Patient: A Case Report. NMC Case Rep J. 2023 Dec 20;10:349-354. doi: 10.2176/jns-nmc.2023-0166. eCollection 2023. |
| 2023 | Ihara K, Ohtani S, Watanabe N, Takahashi N, Hori S, Nakahara J, Takizawa T. Response to letter: "Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule" by Suzuki et al. J Neurol Sci. 2023 Dec 15;455:122785. doi: 10.1016/j.jns.2023.122785. |
| 2023 | Ohtani S, Watanabe N, Ihara K, Takahashi N, Miyazaki N, Ishizuchi K, Takemura R, Hori S, Nakahara J, Takizawa T. Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study. BMC Neurol. 2023 Nov 14;23(1):404. doi: 10.1186/s12883-023-03449-3. |
| 2023 | Takizawa T, Ihara K, Uno S, Ohtani S, Watanabe N, Imai N, Nakahara J, Hori S, Garcia-Azorin D, Martelletti P. Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review. Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):951-967. doi: 10.1080/17425255.2023.2280221. |
| 2023 | Ihara K, Ohtani S, Watanabe N, Takahashi N, Miyazaki N, Takemura R, Hori S, Nakahara J, Takizawa T. Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosing. J Neurol Sci. 2023 Oct 15;453:120811. doi: 10.1016/j.jns.2023.120811. |
| 2023 | Iba C, Ohtani S, Lee MJ, Huh S, Watanabe N, Nakahara J, Peng KP, Takizawa T. Migraine triggers in Asian countries: a narrative review. Front Neurol. 2023 May 3;14:1169795. doi: 10.3389/fneur.2023.1169795. eCollection 2023. |
| 2023 | Ihara K, Ohtani S, Watanabe N, Takahashi N, Miyazaki N, Ishizuchi K, Hori S, Takemura R, Nakahara J, Takizawa T. Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study. J Headache Pain. 2023 Mar 9;24(1):23. doi: 10.1186/s10194-023-01556-7. |
| 2022 | Komatsu M, Ichikawa H, Chiwaki F, Sakamoto H, Komatsuzaki R, Asaumi M, Tsunoyama K, Fukagawa T, Matsushita H, Boku N, Matsusaki K, Takeshita F, Yoshida T, Sasaki H. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Oncogene. 2022 Oct;41(43):4779-4794. doi: 10.1038/s41388-022-02469-6. |
| 2022 | Hori Y, Aruga Y, Ikeda C, Maeshima AM, Izutsu K, Matsushita H. Cerebrospinal fluid infiltration of primary cutaneous gamma delta T-cell lymphoma. EJHaem. 2021 Nov 24;3(1):239-240. doi: 10.1002/jha2.329. eCollection 2022 Feb. |
| 2022 | Fukuhara S, Oshikawa-Kumade Y, Kogure Y, Shingaki S, Kariyazono H, Kikukawa Y, Koya J, Saito Y, Tabata M, Yoshifuji K, Mizuno K, Miyagi-Maeshima A, Matsushita H, Sugiyama M, Ogawa C, Inamoto Y, Fukuda T, Sugano M, Yamauchi N, Minami Y, Hirata M, Yoshida T, Kohno T, Kohsaka S, Mano H, Shiraishi Y, Ogawa S, Izutsu K, Kataoka K. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. Cancer Sci. 2022 Aug;113(8):2763-2777. doi: 10.1111/cas.15427. |
| 2022 | Kojima N, Arai Y, Satomi K, Kubo T, Matsushita Y, Mori T, Matsushita H, Ushijima T, Yatabe Y, Shibata T, Yonemori K, Ichimura K, Ichikawa H, Kawai A, Yoshida A. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall. Mod Pathol. 2022 Oct;35(10):1439-1448. doi: 10.1038/s41379-022-01078-8. |
| 2022 | Tsubokura M, Adegawa Y, Kojima M, Tanosaki R, Ohtake R, Kase Y, Iwashita N, Kasane M, Nakabayashi S, Takeuchi S, Kato K, Boku N, Kanemitsu Y, Okusaka T, Fujimoto H, Yonemori K, Ishiki H, Kawamura K, Satomi E, Matsushita H. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience. BMC Cancer. 2022 Mar 14;22(1):268. doi: 10.1186/s12885-022-09298-6. |
| 2022 | Mise-Omata S, Ikeda M, Takeshita M, Uwamino Y, Wakui M, Arai T, Yoshifuji A, Murano K, Siomi H, Nakagawara K, Ohyagi M, Ando M, Hasegawa N, Saya H, Murata M, Fukunaga K, Namkoong H, Lu X, Yamasaki S, Yoshimura A. Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant. J Immunol. 2022 Dec 1;209(11):2104-2113. doi: 10.4049/jimmunol.2200525. |
| 2022 | Yahagi K, Arai T, Katagiri H, Yatabe Y, Yokota H, Nagai Y, Mitsuhashi T, Wakui M, Murata M. Performance evaluation of a novel reticulocyte identification method that uses metachromatic nucleic acid staining based on a crossover analysis of emission DNA/RNA light (RNP Determination™) in hematology analyzer Celltac G. Int J Lab Hematol. 2022 Dec;44(6):1050-1059. doi: 10.1111/ijlh.13947. |
| 2022 | Wakui M, Uwamino Y, Yatabe Y, Nakagawa T, Sakai A, Kurafuji T, Shibata A, Tomita Y, Noguchi M, Tanabe A, Arai T, Ohno A, Yokota H, Uno S, Yamasawa W, Sato Y, Ikeda M, Yoshimura A, Hasegawa N, Saya H, Murata M. Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assay. Eur J Immunol. 2022 Dec;52(12):1961-1971. doi: 10.1002/eji.202249794. |
| 2022 | Yoshida M, Kobashi Y, Shimazu Y, Saito H, Yamamoto C, Kawamura T, Wakui M, Takahashi K, Ito N, Nishikawa Y, Zhao T, Tsubokura M. Time course of adverse reactions following BNT162b2 vaccination in healthy and allergic disease individuals aged 5-11 years and comparison with individuals aged 12-15 years: an observational and historical cohort study. Eur J Pediatr. 2023 Jan;182(1):123-133. doi: 10.1007/s00431-022-04643-0. |
| 2022 | Uwamino Y, Kurafuji T, Takato K, Sakai A, Tanabe A, Noguchi M, Yatabe Y, Arai T, Ohno A, Tomita Y, Shibata A, Yokota H, Yamasawa W, Namkoong H, Sato Y, Hasegawa N, Wakui M, Murata M; Keio Donner Project Team. Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine. Vaccine. 2022 Jul 30;40(32):4538-4543. doi: 10.1016/j.vaccine.2022.06.016. |
| 2022 | Uwamino Y, Yokoyama T, Shimura T, Nishimura T, Sato Y, Wakui M, Kosaki K, Hasegawa N, Murata M. The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals. Vaccine. 2022 Mar 18;40(13):1928-1931. doi: 10.1016/j.vaccine.2022.02.047. |
| 2022 | Uwamino Y, Kurafuji T, Sato Y, Tomita Y, Shibata A, Tanabe A, Yatabe Y, Noguchi M, Arai T, Ohno A, Yokota H, Yamasawa W, Uno S, Nishimura T, Hasegawa N, Saya H, Wakui M, Murata M; Keio Donner Project Team. Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and university staff. Vaccine. 2022 Feb 11;40(7):1019-1025. doi: 10.1016/j.vaccine.2022.01.002. |
| 2022 | Kurano M, Morita Y, Nakano Y, Yokoyama R, Shimura T, Qian C, Xia F, He F, Zheng L, Ohmiya H, Kishi Y, Okada J, Yoshikawa N, Nakajima K, Nagura Y, Okazaki H, Jubishi D, Moriya K, Seto Y, Yasui F, Kohara M, Wakui M, Kawamura T, Kodama T, Yatomi Y. Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers. Int Immunopharmacol. 2022 Feb;103:108491. doi: 10.1016/j.intimp.2021.108491. |
| 2022 | Yamayoshi S, Iwatsuki-Horimoto K, Okuda M, Ujie M, Yasuhara A, Murakami J, Duong C, Hamabata T, Ito M, Chiba S, Kobayashi R, Takahashi S, Mitamura K, Hagihara M, Shibata A, Uwamino Y, Hasegawa N, Ebina T, Izumi A, Kato H, Nakajima H, Sugaya N, Seki Y, Iqbal A, Kamimaki I, Yamazaki M, Kawaoka Y, Furuse Y. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022. Emerg Infect Dis. 2022 Nov;28(11):2198-2205. doi: 10.3201/eid2811.221127. |
| 2022 | Li Y, Watanabe E, Kawashima Y, Plichta DR, Wang Z, Ujike M, Ang QY, Wu R, Furuichi M, Takeshita K, Yoshida K, Nishiyama K, Kearney SM, Suda W, Hattori M, Sasajima S, Matsunaga T, Zhang X, Watanabe K, Fujishiro J, Norman JM, Olle B, Matsuyama S, Namkoong H, Uwamino Y, Ishii M, Fukunaga K, Hasegawa N, Ohara O, Xavier RJ, Atarashi K, Honda K. Identification of trypsin-degrading commensals in the large intestine. Nature. 2022 Sep;609(7927):582-589. doi: 10.1038/s41586-022-05181-3. |
| 2022 | Misawa K, Nishimura T, Kashimura S, Enoki Y, Taguchi K, Uno S, Uwamino Y, Matsumoto K, Hasegawa N. In vitro effects of diazabicyclooctane β-lactamase inhibitors relebactam and nacubactam against three subspecies of Mycobacterium abscessus complex. Int J Antimicrob Agents. 2022 Nov-Dec;60(5-6):106669. doi: 10.1016/j.ijantimicag.2022.106669. |
| 2022 | Wang QS, Edahiro R, Namkoong H, Hasegawa T, Shirai Y, Sonehara K, Tanaka H, Lee H, Saiki R, Hyugaji T, Shimizu E, Katayama K, Kanai M, Naito T, Sasa N, Yamamoto K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Ichikawa M, Nakamura A, Harada S, Sandhu Y, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, et al. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. Nat Commun. 2022 Aug 22;13(1):4830. doi: 10.1038/s41467-022-32276-2. |
| 2022 | Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, Tanaka H, Azekawa S, Mikami Y, Lee H, Hasegawa T, Okudela K, Okuzaki D, Motooka D, Kanai M, Naito T, Yamamoto K, Wang QS, Saiki R, Ishihara R, Matsubara Y, Hamamoto J, Hayashi H, Yoshimura Y, Tachikawa N, Yanagita E, Hyugaji T, Shimizu E, Katayama K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Aoki R, Nakamura A, Harada S, Sasano H, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022 Sep;609(7928):754-760. doi: 10.1038/s41586-022-05163-5. |
| 2022 | Tanaka H, Asakura T, Suzuki S, Okamori S, Kusumoto T, Ogawa T, Uno S, Morita A, Lee H, Namkoong H, Kamata H, Sato Y, Uwamino Y, Nishimura T, Ishii M, Fukunaga K, Hasegawa N. Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study. BMC Pulm Med. 2022 May 21;22(1):202. doi: 10.1186/s12890-022-01991-3. |
| 2022 | Abe K, Kabe Y, Uchiyama S, Iwasaki YW, Ishizu H, Uwamino Y, Takenouchi T, Uno S, Ishii M, Maruno T, Noda M, Murata M, Hasegawa N, Saya H, Kitagawa Y, Fukunaga K, Amagai M, Siomi H, Suematsu M, Kosaki K; Keio Donner Project. Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19. Sci Rep. 2022 Jan 25;12(1):1299. doi: 10.1038/s41598-022-05424-3. |
| 2022 | Takei H, Nishina N, Namkoong H, Suzuki K, Uwamino Y, Hasegawa N, Takeuchi T. Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study. Mod Rheumatol. 2022 Apr 18;32(3):534-540. doi: 10.1093/mr/roab032. |
| 2022 | Uwamino Y, Nagata M, Aoki W, Kato A, Daigo M, Ishihara O, Igari H, Inose R, Hasegawa N, Murata M. Efficient automated semi-quantitative urine culture analysis via BD Urine Culture App. Diagn Microbiol Infect Dis. 2022 Jan;102(1):115567. doi: 10.1016/j.diagmicrobio.2021.115567. |
| 2022 | Iketani O, Komeya A, Enoki Y, Taguchi K, Uno S, Uwamino Y, Matsumoto K, Kizu J, Hasegawa N. Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection. J Infect Chemother. 2022 Jan;28(1):61-66. doi: 10.1016/j.jiac.2021.10.003. |
| 2022 | Yoshifuji A, Ishioka K, Masuzawa Y, Suda S, Murata S, Uwamino Y, Fujino M, Miyahara H, Hasegawa N, Ryuzaki M, Hoshino H, Sekine K.COVID-19 vaccine induced interstitial lung disease. J Infect Chemother. 2022 Jan;28(1):95-98. doi: 10.1016/j.jiac.2021.09.010. |
| 2022 | Mori T, Koda Y, Kato J, Sakurai M, Uwamino Y, Hasegawa N. Usefulness of the FilmArray Meningitis/Encephalitis Panel in diagnosis of central nervous system infection after allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2022 Jan;30(1):5-8. doi: 10.1007/s00520-021-06474-5. |
| 2022 | Uno S, Takano Y, Iketani O, Abiko T, Miwa T, Nanki K, Kurihara T, Tamura Y, Ara M, Uwamino Y, Shinjoh M, Mori T, Hasegawa N. Digestive Decolonization of Colorectal Carriage of Vancomycin-resistant Enterococcus faecium in a Japanese Adult. Intern Med. 2022 Jan 15;61(2):249-252. doi: 10.2169/internalmedicine.6088-20. |
| 2022 | Imaeda S, Inohara T, Yoshijima N, Kobari Y, Myojin S, Ryuzaki T, Hattori O, Shinada K, Tsuruta H, Takahashi T, Yamazaki M, Kato J, Yamada Y, Jinzaki M, Shimizu H, Fukuda K, Hayashida K. Natural History of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A 5-Year Follow-Up Study. J Am Heart Assoc. 2022 Dec 6;11(23):e026334. doi: 10.1161/JAHA.122.026334. |
| 2022 | Kimura M, Shinada K, Miura K, Endo J, Tsuruta H, Itabashi Y, Katsumata Y, Kimura T, Takatsuki S, Fukuda K, Kanazawa H. Reduction of Atrial Septal Defect Size After Catheter Ablation for Atrial Tachyarrhythmia and Its Predictive Factors. CJC Pediatr Congenit Heart Dis. 2022 Sep 8;1(5):241-244. doi: 10.1016/j.cjcpc.2022.08.001. eCollection 2022 Oct. |
| 2022 | Sugiura K, Kohno T, Hayashida K, Fujisawa D, Kitakata H, Nakano N, Saito T, Hase H, Yoshijima N, Tsuruta H, Itabashi Y, Kohsaka S, Fukuda K.Elderly aortic stenosis patients' perspectives on treatment goals in transcatheter aortic valvular replacement. ESC Heart Fail. 2022 Aug;9(4):2695-2702. doi: 10.1002/ehf2.14008. |
| 2022 | Kobari Y, Inohara T, Imaeda S, Myojin S, Ryuzaki T, Saito T, Yoshijima N, Tanaka M, Tsuruta H, Yashima F, Shimizu H, Fukuda K, Hayashida K.Late expansion of mechanically expanding transcatheter aortic valves. Cardiovasc Interv Ther. 2022 Oct;37(4):717-724. doi: 10.1007/s12928-022-00837-3. |
| 2022 | Takizawa T, Ohtani S, Watanabe N, Miyazaki N, Ishizuchi K, Sekiguchi K, Iba C, Shibata M, Takemura R, Hori S, Nakahara J. Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis. BMC Neurol. 2022 Dec 31;22(1):512. doi: 10.1186/s12883-022-03041-1. |
| 2022 | Shimohama S, Iizuka T, Takizawa T, Watanabe N, Tezuka T, Matsuda K, Yamanoi K, Kanazawa N, Kawamura Y, Yoshikawa T, Suzuki T, Takao M, Nakahara J, Izawa Y. Anti-N-methyl-D-aspartate receptor encephalitis with concurrent human herpes virus-6A deoxyribonucleic acid detection: An autopsy case. Neuropathology. 2023 Jun;43(3):257-261. doi: 10.1111/neup.12881. |
| 2022 | Sekiguchi K, Watanabe N, Miyazaki N, Ishizuchi K, Iba C, Tagashira Y, Uno S, Shibata M, Hasegawa N, Takemura R, Nakahara J, Takizawa T.Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study. Cephalalgia. 2022 Mar;42(3):266-272. doi: 10.1177/03331024211038654. |
| 2013 | Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, Yamashita H, Satoh Y, Hashimoto H, Egashira T, Seki T, Muraoka N, Yamakawa H, Ohgino Y, Yuasa S, Murata M, Suematsu M, Fukuda K.：Distinct metabokic flow enables large-scale purification of pluripotent stem cell-derived cardiomyocytes. Cell Stem 12(1):127-37 2013. |
| 2012 | Yokoyama K, Kojima T, Sakata Y, Kawasaki T, Tsuji H, Miyata T, Okamoto S, Murata M: A survey of the clinical course and management of Japanese patients deficient in natural anticoagulants. Clin Appl Thromb Hemost 18(5) pp506-513 2012. |
| 2012 | Ono Y, Wang Y, Suzuki H, Okamoto S, Ikeda Y, Murata M, Poncz M, Matsubara Y: Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf. Blood Nov 1;120(18):3812-3821 2012. |
| 2012 | Igari A, Nakagawa T, Moriki T, Yamaguchi Y, Matsumoto M, Fujimura Y, Soejima K, Murata M: Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non-functional effects on catalytic activity. Thromb Res 130(3)pp.79-83 2012. |
| 2012 | Yamaguchi Y, Abe T, Sato Y, Matsubara Y, Moriki T, Murata M: Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: A systematic review and meta-analysis. Platelets. 2012. |
| 2012 | Koyama Y, Homma K, Miwa M, Ikeda K, Murata M, Hasegawa T: Measurement of reference intervals for urinary free adrenal steroid levels in Japanese newborn infants by using stable isotope dilution gas chromatography/mass spectrometry. Clin Chim Acta. 415C:302-305 2012. |
| 2012 | Arai T, Kawamura A, Matsubara Y, Yokoyama K, Ikeda Y, Fukuda K, Murata M: Effect of chronic kidney disease on platelet reactivity to dual-antiplatelet therapy in patientstreated with drug-eluting stents. Heart Vessels. Vol.27,No.5 pp.480-485. 2012. |
| 2012 | okoyama K, Murata M, Ikeda Y, Okamoto S: Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma. Thromb Res. 130(1)pp.7-11 2012. |
| 2012 | Koyama Y, Homma K, Fukami M, Miwa M, Ikeda K, Ogata T, Hasegawa T, Murata M: Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone. Clin Chem. Vol.58,No.4 pp.741-747 2012. |
| 2012 | Yamazaki H, Chijiwa T, Inoue Y, Abe Y, Suemizu H, Kawai K, Wakui M, Furukawa D, Mukai M, Kuwao S, Saegusa M, Nakamura M: Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med. Vol. 3 No. 5 pp. 793-796 2012. |
| 2011 | Yamaguchi Y, Moriki T, Igari A, Nakagawa T, Wada H, Matsumoto M, Fujimura Y, Murata M: Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Thrombosis Research Vol.128 pp.169-173 2011. |
| 2011 | Kurata Y, Fujimura K, Kuwana M, Tomiyama Y, Murata M: Epidemiology of primary immune thrombocytopenia in children and adults in Japan : a population-based stuby and literature review. Int J Hematol Vol93 pp.329-335 2011. |
| 2011 | Morikawa T, Murata M, Okuda S, Tsuruta H, Iwanaga S, Murata M, Satoh T, Ogawa S, Fukuda K: Quantitative analysis of right ventricular function in patients with pulmonary hypertension using three-dimensional echocardiography and a two-dimensional summation method compared to magnetic resonance imaging. Am J Cardiol. Vol.107,No.3 pp.484-489 2011. |
| 2011 | Mori T, Nakamura Y, Kato J, Sugita K, Murata M, Kamei K, Okamoto S: Fungemia due to Rhodotorula mucilaginosa after allpgeneic hematopoietic stem cell transplantation. Transplant Infectious Disease Vo.14 pp.91-94 2011. |
| 2011 | Fujimura Y, Matsumoto M, Isonishi A, Yagi H, Kokame K, Soejima K, Murata M, Miyata T: Natural history of Upshaw-schlman syndrome based on ADAMTS13 gene aualysis in Japan. Journal of Thrombosis and Haemostasis. Vol.9,No.1 pp.283-301 2011. |
| 2011 | Ono M, Matsubara Y, Shibano T, Ikeda Y, Murata M: GSK-3βnegatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro. Platelets Vol.22,No.3 pp.196-203 2011. |
| 2011 | Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda Y, Kobayashi Y, Murata M, Okamoto S, Takeda J, Tanabe M, Sakakura Y, Ginba H, Kitajima M, Kitagawa Y: The role of a real-time PCR technology for rapid detection and identification of bacterial and fungal pathogens in whole-blood samples. J Infect Chemother. 17(3) pp.327-333 2011. |
| 2011 | Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnaoi M, Wakui M, Ito M, Suematsu M, Peltz G, Nakamura M, Suemizu1 M: The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochem. Biophys. Res. Commun. Vol. 405 No. 3 pp. 405-410 2011. |
| 2011 | Hayasaka T, Goto-Inoue N, Ushijima M, Yao I, Yuba-Kubo A, Wakui M, Shigeki Kajihara S, Matsuura M, Setou M: Development of imaging mass spectrometry (IMS) dataset extract software, IMS convolution. Anal. Bioanal. Chem. Vol. 401 No. 1 pp. 183-193 2011. |
| 2011 | Kubo A, Ohmura M, Wakui M, Takeshita K, Harad T, Kajihara S, Ogawa K, Suemizu H, Nakamura M, Setou M, Suematsu M: Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice. Anal. Bioanal. Chem. Vol. 400 No. 7 pp. 1895-1904 2011. |
| 2011 | Yamauchi Y, Izumi Y, Asakura K, Fukutomi T, Serizawa A, Kawai K, Wakui M, Suematsu M, Nomori H: Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells. Biochem. Biophys. Res. Commun. Vol. 410 No. 2 pp. 328-332 2011. |
| 2011 | Asakura K, Izumi Y, Yamamoto M, Yamauchi Y, Kawai K, Serizawa A, Mizushima, T, Ohmura M, Kawamura M, Wakui M, Adachi T, Nakamura M, Suematsu M, Nomori H: The cytostatic effects of lovastatin on ACC-MESO-1 cells. J. Surg. Res. Vol. 170 No. 2 pp. e197-209, 2011. |
| 2011 | Ono Y, Kawachi S, Hayashida T, Wakui M, Tanabe M, Itano O, Obara H, Shinoda M, Hibi T, Oshima G, Tani N, Mihara K, Kitagawa Y: The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery. Vol. 150 No. 2 pp. 154-161, 2011. |
| 2011 | Nagai T, Kohsaka S, Murata M, Okuda S, Anzai T, Sato T, Fukuda K：Significance of electrocardiographic right ventricular hypertrophy in patients with pulmonary hypertension or without right ventricular dysfunction. J Am Coll Cardiol. 57: E149. 2011. |
| 2011 | Egashira T, Murata M, Yasuda R, Suzuki K, Tsuruta H, Akaiashi M, Fukuda K：Three-dimensional echocardiography findings of biventricular thrombi complicated by cerebral embolism. J Echocardiography. 9: 163-164 2011. |
| 2011 | Shinmura K, Tamaki K, Sano M, Murata M, Yamakawa H, Fukuda K. Impact of caloric restriction on cardiac senescence：Caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol. 50: 117-127. 2011. |
| 2011 | Matsubara Y, Suzuki H, Ikeda Y, Murata M: Generation of megakaryocytes and platelets from preadipocyte cell line 3T3-L1, but not the parent cell line 3T3, in vitro. Biochem Biophys Res Commun Vol.402,No.4 pp.796-800 2011. |
| 2010 | Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M: Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection Kit. Critical Care Vol.14,NoR.159 pp.1-9 2010. |
| 2010 | Masahiro M, Wakui M, Monnai M, Mizushima T, Nishime C, Kawai K, Ohmura M, Suemizu H, Hishiki T, Suematsu M, Murata M, Chijiwa T, Furukawa D, Ogoshi K, Makuuchi H and Nakamura M: Reduced CD73 Expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastases. ONCOLOGY LETTERS Vol.1 pp.431-436 2010. |
| 2010 | Teramoto T, Shimada K, Uchiyama S, Sugawara M, Goto Y, Yamada N, Oikawa S, Ando K, Ishizuka N, Yamazaki T, Yokoyama K, Murata M, Ikeda Y: Raionale,desing,and baseline data of the Japanese Primary Prevention Project(JPPP)-A randomized,open-ladel,contorlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events. Am Heart J Vol.159,No.3 pp.361-369 2010. |
| 2010 | Ochi Y, Suzuki M, Imaoka T, Murata M, Nishihara H, Einaga Y, Yamamoto K: Controlled storage of ferrocene derivatives as redox-active molecules in dendrimers. J Am Chem 132(14) pp.5061-5069 2010. |
| 2010 | Moriki T, Maruyama IN, Igari A, Ikeda Y, Murata M: Identification of ADAMTS13 peptide sequences binding to von Willebrand factor. Biochem Biophys Res Commun Vol.391,No.1 pp.783-788 2010. |
| 2010 | Kato J, Mori T, Sugita K, Murata M, Ono Y, Yamane A, Shimizu T, Okamoto S: Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia. Int J Hematol Vol.91,No.5 pp.912-913 2010. |
| 2010 | Ito N, Wada H, Matsumoto M, Fujimura Y, Murata M, Izuno T, Sugita M, Ikeda Y: A second national questionnaire survey of TMA. Int J Hematol Vol.92,No.1 pp.68-75 2010. |
| 2010 | Handa K, Ohmura M, Nishime C, Hishiki T, Nagahata Y, Kawai K, Suemizu H, Nakamura M, Wakui M, Kitagawa Y, Suematsu M, Tsukada K: Phosphorescence-assisted microvascular O2 measurements reveal alterations of oxygen demand in human metastatic colon cancer in the liver of superimmunodeficient NOG mice. Adv. Exp. Med. Biol. Vol. 662 pp.423-429 2010. |
| 2010 | Yuasa S, Onizuka T, Shimoji K, Ohno Y, Kageyama T, Yoon SH, Egashira T, Seki T, Hasimoto H, Nishiyama T, Kaneda R, Murata M, Hattori F, Makino S, Sano M, Ogawa S, WJ Prall O, Harvey RP, Fukuda K：Zac1 is an essential transcription factor for cardiac morphogenesis. Circ Res. 106: 1083-1091. 2010. |
| 2010 | Murata M, Tohyama S, Fukuda K. The impact of recent advances in cardiovascular regenerative medicine on clinical therapeutics and drug discovery. Pharmacology & Therapeutics 126: 109-118. 2010. |
| 2010 | Neely GG, Kuba K, Cammarato A, Isobe K, Amann S, Zhang L, Murata M, Elmén L, Gupta V, Arora S, Sarangi R, Dan D, Fujisawa S, Usami T, Xia CP, Keene AC, Alayari KN, Yamakawa H, Elling U, Berger C, Novatchkova M, Koglgruber R, Fukuda K, Nishina H, Isobe M, Pospisilik JA, Imai Y, Pfeufer A, Hicks AA, Pramstaller PP, Subramaniam S, Kimura A, Ocorr K, Bodmer R, Penninger JM：A novel in vivo Drosophia RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell 106: 142-153. 2010. |
| 2010 | Hattori F, Chen H, Yamashita H, Tohyama S, Satoh Y, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shimoji K, Ohno Y, Egashira T, Kaneda R, Murata M, Hidaka K, Morisaki T, Sasaki E, Suzuki T, Sano M, Makino S, Oikawa S, Fukuda K：A non-genetic method for purifying stem cell-derived cardiomyocytes. Nature Methods 7: 61-66. 2010. |
| 2009 | Motoda H, Murata M, Iwanaga S, Matsushita K, Nakamizo H, Wakino S, Murata M, Ogawa S: Parachute mitral valve incidentally diagnosed in an adult patient with hypertension. J Echocardiography. 2009. |
| 2009 | Matsubara Y, Suzuki H, Ikeda Y, Murata M: Generation of megakaryocytes and platelets from human subcutaneous adipose tissues. Biochem Biophys Res Commun Vol.378,No.4 pp.716-720 2009. |
| 2009 | Homma K, Hida M, Ikeda K, Yamaga N, Murata M, Hasegawa T: Measurement of Serum 17α-hidroxyprogesterone in Newborn Infants by Stable Dilution- Gas Chromatography/Mass Spectrometry. Clinical Pediatric Endocrinology Vol.18,No.3 pp.77-80 2009. |
| 2009 | Ishikawa J, Okada H, Kato H, Takeshita S, Honda S, Kawasaki T, Suehisa E, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Ikeda Y, Kokubo Y, Okamura T, Tomoike H, Miyata T: Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level. Blood Coagul Fibrinolysis Vol.20,No.1 pp.22-26 2009. |
| 2009 | Fujimura Y, Matsumoto M, Kokame K, Isonishi A, Soejima K, Akiyama N, Tomiyama J, Natori K, Kuranishi Y, Imamura Y, Inoue N, Higasa S, Seike M, Kozuka T, Hara M, Wada H, Murata M, Ikeda Y, Miyata T, George JN: Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol Vol.144,No.5 pp.742-754 2009. |
| 2009 | Katayama T, Murata M, Iwanaga S, Kawamura A, Yoshikawa T, Ogawa S: Left ventricular pseudoaneurysm with peculiar coronary artery collapse. J Am Coll Cardiol Vol. 53 No. 19 pp. 1823 2009. |
| 2009 | Ito N, Wada H, Matsumoto M, Fujimura Y, Murata M, Izuno T, Sugita M, Ikeda Y: National questionnaire survey of TMA. Int J Hematol Vol.90, No. 3 pp. 328-335 2009. |
| 2009 | Chijiwa T, Abe Y, Ikoma N, Yamazaki H, Tsukamoto H, Suemizu H, Kawai K, Wakui M, Nishime C, Matsumoto H, Matsuyama M, Mukai M, Ueyama Y, Nakamura M: Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gCnull (NOG) mice. Int. J. Oncol. Vol.34 No. 1 pp. 5-13 2009. |
| 2009 | Harada T, Yuba-Kubo A, Sugiura Y, Zaima N, Hayasaka T, Goto-Inoue N, Wakui M, Suematsu M, Takeshita K, Ogawa K, Yoshida Y, Setou M: Visualization of volatile substances in different organelles with an atmospheric-pressure Mass Microscope. Anal. Chem. Vol. 81 No. 21 pp. 9153-9157 2009. |
| 2009 | Suzuki R, Hattori F, Itabashi Y, Yoshioka M, Yuasa S, Manabe-Kawaguchi H, Murata M, Makino S, Kokaji K, Yozu R, Fukuda K：Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun. Vol. 387： pp.353-359 2009. |
| 2009 | Tanaka T, Tohyama S, Murata M, Nomura F, Kaneko T, Chen H, Hattori F, Egashira T, Seki T, Ohno Y, Koshimizu U, Yuasa S, Ogawa S, Yamanaka S, Yasuda K, Fukuda K：In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun Vol.385 pp.497-502 2009. |
| 2009 | Tokudome S, Sano M, Shinmura K, Matsuhashi T, Morizane S, Moriyama H, Tamaki K, Nakanishi H, Yoshikawa N, Shimizu N, Endo J, Katayama T, Murata M, Yuasa S, Kaneda R, Tomita K, Eguchi N, Urade Y, Asano K, Utsunomiya Y, Suzuki T, Taguchi R, Tanaka H, Fukuda K：Glucocorticoid protects heart from ischemia-reperfusion injury through activation of lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest. Vol.119 pp.1477-1488. 2009. |
| 2009 | Hyodo M, Makino S, Awaji Y, Sakurada Y, Ohkubo T, Murata M, Fukuda K, Tsuda M：A novel in vitro system for cardiomyocyte differentiation with embryonic cells of the medaka (Oryzias latipes). Int J Dev Biol. Vol.53 pp.615-622. 2009. |
| 2009 | Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, Nakano Y, Kamata H, Hasegawa N, Ishizaka A: Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration Vol.78,No.3 pp.285-292. 2009. |
| 2009 | Tasaka S, Hasegawa N, Nishimura T, Yamasawa W, Kamata H, Shinoda H, Kimizuka Y, Fujiwara H, Hirose H, Ishizaka A: Elevated Serum Adiponectin Level in Patients with Mycobacterium avium-intracellulare Complex Pulmonary Disease. Respiration. 2009. |
| 2009 | Shimizu M, Hasegawa N, Nishimura T, Endo Y, Shiraishi Y, Yamasawa W, Koh H, Tasaka S, Shimada H, Nakano Y, Fujishima S, Yamaguchi K, Ishizaka A: Effects of tumor necrosis factor-a converting enzyme inhibition on acute lung injury induced by endotoxin in the rat. Shock. 2009. |
| 2008 | Takahashi S, Ushida M, Komine R, Shimodaira A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M: Platelet responsiveness to in vitro aspirin is independent of COX-1 and COX-2 protein levels and polymorphisms. Thrombosis Research. Vol.121,No.4 pp.509-517 2008. |
| 2008 | Matsubara Y, Murata M, Watanabe G, Ikeda Y: Enhancing effect of the (145)Met-allele of GPIb alpha on platelet sensitivity to aspirin under high-shear conditions. Thrombosis Research Vol.123,No.2 pp.331-335 2008. |
| 2008 | Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Watanabe G, Murata M, Ikeda Y: Alpha 2A adrenergic receptor polymorphism is associated with plasma von Willebrand factor levels in a general population. Blood Coagul Fibrinolysis. 19(5) pp.395-399 2008. |
| 2008 | Higashi T, Wakui M, Nakano K, Hashimoto K, Takagi R, Tanaka Y, Matsushita S: Evaluation of adjuvant activities using human antigen presenting cells in vitro. Allergol. Int. Vol.57 No.3 pp.219-222 2008. |
| 2008 | Suemizu H, Hasegawa M, KawaiK, Taniguchi K, Monnai M, Wakui M, Suematsu M, Ito M, Peltz G, Nakamura M：Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice. Biochem. Biophys. Res. Commun. Vol.377 pp.248-252 2008. |
| 2008 | Murata M, Iwanaga S, Tamura Y, Kondo M, Kouyama K, Murata M, Ogawa S：A real-time 3-dimensional echocardiographic quantitative analysis of left atrial function in left ventricular diastolic dysfunction. Am J Cardiol. Vol.102 pp.1097-1102. 2008. |
| 2008 | Chen H, Hattori F, Murata M, Li W, Yuasa S, Onitsuka T, Shimoji K, Ohno Y, Sasaki E, Kimura K, Hakuno D, Sano M, Makino S, Ogawa S, Fukuda K：Common marmoset embryonic stem cell can differentiate into cardiomyocytes. Biochem Biophys Res Commun. Vol.369 pp.801-806. 2008. |
| 2008 | Saito F, Tasaka S, Inoue K, Miyamoto K, Nakano Y, Ogawa Y, Yamada W, Shiraishi Y, Hasegawa N, Fujishima S, Takano H, Ishizaka A: Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol pp.11-10. 2008. |
| 2008 | Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, Ogawa Y, Miyamoto K, Nakano Y, Hasegawa N, Miyasho T, Maruyama I, Ishizaka A: Role of Soluble Receptor for Advanced Glycation End-Products on Endotoxin-Induced Lung Injury. Am J Respir Crit Care Med Vol.178,No.4. 2008. |
| 2008 | Yamada W, S Tasaka S, Koh H, Shimizu M, Ogawa Y, Hasegawa N, Miyasho T, Yamaguchi K, Ishizaka A: Role of toll-like receptor 4 in acute neutrophilic lung inflammation induced by intratracheal bacterial products in mice. Journal of Inflammation Research Vol.1 pp.1-10. 2008. |
| 2007 | Yada H, Murata M, Shimoda K, Yuasa S, Kawaguchi H, Ieda M, Adachi T, Murata M, Ogawa S, Fukuda K: Dominant negative suppression of Rad leads to QT prolongation and causes ventricular arrhythmias via modulation of L-type Ca2+ channels in the heart. Circulation Research Vol.101,No.1 pp.69-77 2007. |
| 2007 | Yin T, Takeshita S, Sato Y, Sakata T, Shin Y, Honda S, Kawasaki T, Tsuji H, Kojima T, Madoiwa S, Sakata Y, Murata M, Ikeda Y, Miyata T: A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency. Thromb Haemost Vol.98,No.4 pp.783-789 2007. |
| 2007 | Wakui M, Nakano K, Matsushita S: Notch ligand mRNA levels of human APCs predict Th1/Th2-promoting activities. Biochem. Biophys. Res. Commun. Vol.358 No.2 pp.596-601 2007. |
| 2007 | Hagiwara Y, Miyoshi S, Fukuda K, Nishiyama N, Ikegami Y, Tanimoto K, Murata M, Takahashi E, Shimoda K, Hirano T, Mitamura H, Ogawa S. SHP2-mediated signaling cascade through gp130 is essential for LIF-ICa,L, [Ca2+]i transient and APD increase in cardiomyocytes. J Mol Cell Cardiol. Vol.43 pp. 710-716. 2007. |
| 2007 | Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cho HC, Marbán E：Gene therapy to inhibit the calcium channel beta subunit. Physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ Res. Vol. 101 pp.167-175. 2007. |
| 2007 | Tomita Y, Makino S, Hakuno D, Hattan N, Kimura K, Miyoshi S, Murata M, Ieda M, Fukuda K：Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Med Biol Eng Comput. Vol.45 pp.209-220. 2007. |
| 2006 | Nishida H, Murata M, Miyaki K, Omae K, Watanabe K, Ikeda Y: Gorog Thrombosis Test: analysis of factors influencing occlusive thrombus formation. Blood Coagul Fibrinolysis Vol.17,No.3 pp.203-207 2006. |
| 2006 | Hattori H, Sato H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N: A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia. Brain Res Vol.1108,No.1 pp.221-223 2006. |
| 2006 | Takahashi S, Ushida M, Komine R, Shimizu A, Uchida T, Ishihara H, Shibano T, Watanabe G, Ikeda Y, Murata M: Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin. Thromb Res Vol.119,No.4 pp.517-524 2006. |
| 2006 | Kimura R, Honda S, Kawasaki T, Tsuji H, Madoiwa S, Sakata Y, Kojima T, Murata M, Nishigami K, Chiku M, Hayashi T, Kokudo Y, Okayama A, Tomoike H, Ikeda Y, Miyata T: ProteinS‐K196E mutation as a genetic risk factor for deep vein thrombosis. BLOOD Vol.107,No.4 pp.1737-1738 2006. |
| 2006 | Hattori H, Sonoda A, Sato H, Ito D, Tnahashi N, Murata M, Saito I, Watanabe K, Suzuki N: G501C polymorphism of oxidized LDL receptor gene (OLR1) and ischemic stroke. Brain Res Vol.1121,No.1 pp.246-249 2006. |
| 2006 | Tsukamoto H, Hirose H, Dan K, Ishii K, Kikuchi H, Murata M: Apolipoprotein E deficiency associated with type III hyperlipoproteinemia--analysis of apolipoprotein E. Rinsho Byori 54(2) pp.121-125 2006. |
| 2006 | Matsubara Y, Murata M, Yoshida T, Watanabe K, Saito I, Miyaki K, Omae K, Ikeda Y: Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT. Biochemical and Biophysical Research Communications Vol.341 pp.128-131. 2006. |
| 2006 | Matsubara Y, Murata M, Watanabe K, Saito I, Miyaki K, Omae K, Ishikawa M, Matsushita K, Iwanaga S, Ogawa S, Ikeda Y: Coronary artery disease and a functional polymorphism of hTERT. Biochem Biophys Res Commun Vol.348,No.2 pp.662-672 2006. |
| 2006 | Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Miyaki K, Omae K, Watanabe G, Murata M, Ikeda Y: Identification of ADRA2A polymorphisms related to shear-mediated platelet function. Biochem Biophys Res Commun Vol.347, No.4 pp.1001-1005 2006. |
| 2006 | Arrell DK, Elliott ST, Kane LA, Guo Y, Pedersen PL, Robinson J, Murata M, Murphy AM, Marbán E, Van Eyk JE：Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res. Vol.99 pp.706-714. 2006. |
| 2005 | Miyaki K, Sutani S, Kikuchi H, Takei I, Murata M, Watanabe K, Omae K: Increased Risk of Obesity Resulting from the Interaction between High Energy Intake and the Trp64Arg Polymorphism of the β3-adrenergic Receptor Gene in Healthy Japanese Men. J Epdemiol Vol.15,No.6 pp.203-210 2005. |
| 2005 | Miyaki K, Murata M, Kikuchi H, Takei I, Nakayama T, Watanabe K, Omae K: Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype. J Hum Genet Vol.50 pp.241-248 2005. |
| 2005 | Isshiki I, Favier R, Moriki T, Uchida T, Ishihara H, Van Dreden P, Murata M, Ikeda Y: Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lankan ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X. Blood Coagulation and Fibrinolysis Vol.16 pp.9-16 2005. |
| 2005 | Miyaki K, Tohyama S, Murata M, Kikuchi H, Takei I, Watanabe K, Omae K: Salt Intake Affects the Relation Between Hypertension and the T-786C Polymorphism in the Endothelial Nitric Oxide Synthase Gene. American Journal of Hypertension Vol.18,No 12 pp.1556-1562 2005. |
| 2005 | Hattori H, Ito D, Tanahashi N, Murata M, Saito I, Watanabe K, Suzuki N: T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease. Neuroscience Letters pp.132-135 2005. |
| 2005 | Matsubara Y, Murata M, Hayashi T, Suzuki K, Okamura Y, Handa M, Ishihara H, Shibano T, Ikeda Y: Platelet glycoprotein Ib alpha polymorphisms affect the interaction with von Willebrand factor under flow conditions. British Journal of Haematology Vol.128 pp.533-539 2005. |
| 2005 | Oguchi S, Ishii K, Moriki T, Takeshita E, Murata M, Ikeda Y, Watanabe K: Factor XII Shizuoka, a novel mutation (Ala392Thr) identified and characterized in a patient with congenital coagulation factor XII deficiency. Thrombosis Research Vol.115,No.3 pp.191-197 2005. |
| 2005 | Miyoshi S, Mitamura H, Fukuda Y, Tanimoto K, Hagiwara Y, Kanki H, Takatsuki S, Murata M, Miyazaki T, Ogawa S: Link between SCN5A mutation and the Brugada syndrome ECG phenotype: simulation study. Circ J 69(5) pp.567-575 2005. |
| 2005 | Wakui M, Morel L, Butfiloski EJ, Kim C, Sobel ES: Genetic dissection of SLE pathogenesis: partial functional complementation between Sle1 and Sle3/5 demonstrates requirement for intracellular co-expression for full phenotypic expression of lupus. J. Immunol. Vol.175No.2 pp.1337-1345 2005. |
| 2005 | Hattan N, Kawaguchi H, Ando K, Kuwabara E, Fujita J, Murata M, Suematsu M, Mori H, Fukuda K：Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res. Vol.65 pp.334-344. 2005. |
| 2004 | Miyaki K, Omae K, Murata M, Tanahashi N, Saito I, Watanabe K: High throughput multiple combination extraction from large scale polymorphism data by Exact Tree Method. J Hum Genetics pp.455-462 2004. |
| 2004 | Murata M, Maruyama T, Suzuki Y, Saruta T, Ikeda Y: Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus. Diabetic Medicine Vol.21,No.8 pp.837-844 2004. |
| 2004 | Uchida T, Wada H, Mizutani M, Iwashita M, Ishihara H, Shibano T, Suzuki M, Matsubara Y, Soejima K, Matsumoto M, Fujimura Y, Ikeda Y, Murata M: Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. Blood Vol.104,No.7 pp.2081-2083 2004. |
| 2004 | Azuma K,Oguchi S,Matsubara M,Mamizuka T,Murata M,Kikuchi H,Watanabe K,Katsukawa F,Yamazaki H, Shimada A,Saruta T: Novel resistin polymorphisms: Association with serum resistin level in Japanese obese individuals. Horm Metab Res 2004. |
| 2004 | Ishii K, Oguchi S, Moriki T, Yatabe Y, Takeshita E, Murata M, Ikeda Y, Watanabe K: Genetic analyses and expression studies identified a novel mutation (W486C) as a molecular basis of congenital coagulation factor XII deficiency. Blood Coagulation and Fibrinolysis Vol.15 pp.367-373 2004. |
| 2004 | Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, Ashida S, Soejima K, Okada Y, Ikeda Y: Detection of von Willebrand factor - cleaving protease (ADAMTS-13) in human platelets. Biochem Biophys Res Commun Vol.313,No.1 pp.212-216 2004. |
| 2004 | Matsunaga S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A, Murata M, Saruta T: Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care Vol.27,No.2 pp.303-307 2004. |
| 2004 | Motohashi Y, Maruyama T, Murata M, Nakano S, Maruyama C, Kyotani S, Tsushima M, Saruta T: Role of genetic factors (CETP gene Taq IB polymorphism and Apo A-1 gene MSP I polymorphism) in serum HDL-C levels in women. Nutr Metab Cardiovasc Dis Vol.14,No.1 pp.6-14 2004. |
| 2004 | Wakui M, Kim J, Butfiloski EJ, Morel L, Sobel ES：Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing. J. Immunol. Vol.173,No12 pp.7368-7376 2004. |
| 2004 | Murata M, Cingolani E, McDonald AD, Donahue JK, Marbán E：Creation of a genetic calcium channel blocker by targeted Gem gene transfer in the heart. Circ Res. Vol.95 pp.398-405. 2004. |
| 2004 | Takahashi E, Fukuda K, Miyoshi S, Murata M, Kato T, Ita M, Tanabe T, Ogawa S：Leukemia inhibitory factor activates cardiac L-Type Ca2+ channels via phosphorylation of serine 1829 in the rabbit Cav1.2 subunit. Circ Res. Vol.94 pp.1242-1248. 2004. |
| 2004 | Azuma K. Oguchi S. Matsubara Y. Mamizuka T. Murata M. Kikuchi H. Watanabe K. Katsukawa F. Yamazaki H. Shimada A. Saruta T: Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res Vol.36 pp.564-570 2004. |
| 2003 | Watanabe R, Ishibashi T, Saitoh Y, Shichishima T, Maruyama Y, Enomoto Y, Handa M, Oda A, Ambo H, Murata M, Ikeda Y: Bernard-Soulier syndrome with a homozygous 13 base pair deletion in the signal peptide-coding region of the platelet glycoprotein Ibβ gene. Blood Coagulation and Fibrinolysis Vol.14,No.4 pp.387-394. 2003. |
| 2003 | Matsubara Y, Murata M, Sugita K., Ikeda Y: Identification of a novel point mutation in platelet glycoprotein Ibα, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease. Journal of Thrombosis and Haemostasis Vol.1,No.10 pp.2198-2205 2003. |
| 2003 | Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T: Correlation between serum resistin level and adiposity in obese individuals. Obesity Research Vol.11,No.8 pp.997-1001 2003. |
| 2003 | Sagawa M, Takao M, Nogawa S, Mizuno M, Murata M, Amano T, Koto A: Wilson's disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura. No To Shinkei Vol.55,No.10 pp.899-902 2003. |
| 2003 | Nakanishi M, Takanami Y, Maruyama T, Murata M, Motohashi Y, Nakano S, Uchida K, Maruyama C, Kyotani S, Tsushima M: The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1 (R192) from PON1 (Q192). Journal of Atherosclerosis and Thrombosis. Vol.10,No.6 pp.337-342 2003. |
| 2003 | Murata M, Sasaki N, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marbán E：MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning. Circulation. Vol.107 pp.1183-1188. 2003. |
| 2003 | Hirano Y, Yoshinaga T, Murata M, Hiraoka M：Prepulse-induced mode 2 gating behavior with and without beta-adrenergic stimulation in cardiac L-type Ca channels. Am J Physiol. Vol.276 pp.C1338-1345. 2003. |
| 2003 | Tasaka S, Ishizaka A, Yamada W, Shimizu M, Koh H, Hasegawa N, Adachi Y, Yamaguchi K: Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. American journal of respiratory cell molecular biology Vol.29,No.2 pp.252-258. 2003. |
| 2003 | Watanabe N, Nakajima H, Suzuki H, Oda Ai, Matsubara Y, Moroi M, Terauchi Y, Kadowaki T, Suzuki H, Koyasu S, Ikeda Y, Handa M: Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation. Blood Vol.102,No.2 pp.541-548 2003. |
| 2002 | Ito D, Tanahashi N, Murata M, Sato H, Saito I, Watanabe K, Fukuuchi Y: Notch3 gene polymorphism and ischaemic cerebrovascular disease. J Neurol Neurosurg Psychiatry 72(3) pp.382-384. 2002. |
| 2002 | Kawano K, Yoshino H, Aoki N, Udagawa H, Watanuki A, Hioki Y, Hasumura Y, Yasumura T, Homori M, Murata M, Ikeda Y, Ishikawa K: Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis. Clinical cardiology Vol.25,No.4 pp.154-160. 2002. |
| 2002 | Matsubara Y, Murata M, Moriki T, Yokoyama K, Watanabe N, Nakajima H, Handa M, Kawano K, Aoki N, Yoshino H, Ikeda Y: A novel polymorphism, 70Leu/Phe, disrupts a consensus leu residue within the leucine-rich repeat sequence of platelet glycoprotein Ibα. Thrombosis and haemostasis Vol.87,No5 pp.867-872. 2002. |
| 2002 | Nishiya T, Kainoh M, Murata M, Handa M, Ikeda Y: Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia / IIa and Ibα under flow conditions：specific synergy of receptor-ligand interactions. Blood Vol.100,No.1 pp.136-142. 2002. |
